Sivik Global Healthcare LLC Has $6.40 Million Position in Surgery Partners, Inc. (NASDAQ:SGRY)

Sivik Global Healthcare LLC raised its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 14.3% during the fourth quarter, HoldingsChannel.com reports. The fund owned 200,000 shares of the company’s stock after acquiring an additional 25,000 shares during the quarter. Surgery Partners accounts for about 2.7% of Sivik Global Healthcare LLC’s holdings, making the stock its 15th largest position. Sivik Global Healthcare LLC’s holdings in Surgery Partners were worth $6,398,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the company. DekaBank Deutsche Girozentrale bought a new position in shares of Surgery Partners during the 3rd quarter valued at about $39,000. Strs Ohio bought a new position in Surgery Partners during the 4th quarter worth $51,000. Signaturefd LLC acquired a new position in shares of Surgery Partners during the 3rd quarter worth approximately $56,000. Nisa Investment Advisors LLC increased its position in shares of Surgery Partners by 69.7% in the third quarter. Nisa Investment Advisors LLC now owns 2,945 shares of the company’s stock worth $86,000 after purchasing an additional 1,210 shares during the period. Finally, Headlands Technologies LLC bought a new stake in shares of Surgery Partners during the 4th quarter worth approximately $145,000.

Insider Activity

In related news, insider Marissa Brittenham sold 1,637 shares of the stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $31.89, for a total transaction of $52,203.93. Following the completion of the transaction, the insider now owns 30,469 shares in the company, valued at $971,656.41. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other news, insider Bradley R. Owens sold 1,040 shares of the stock in a transaction on Monday, February 12th. The stock was sold at an average price of $35.22, for a total transaction of $36,628.80. Following the completion of the transaction, the insider now owns 73,149 shares in the company, valued at approximately $2,576,307.78. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Marissa Brittenham sold 1,637 shares of the stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $31.89, for a total transaction of $52,203.93. Following the transaction, the insider now owns 30,469 shares of the company’s stock, valued at approximately $971,656.41. The disclosure for this sale can be found here. Insiders sold a total of 18,774 shares of company stock valued at $608,352 in the last ninety days. 2.60% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

SGRY has been the topic of a number of research analyst reports. Barclays initiated coverage on shares of Surgery Partners in a research note on Wednesday, March 6th. They issued an “equal weight” rating and a $35.00 price target on the stock. Royal Bank of Canada restated an “outperform” rating and set a $49.00 price target on shares of Surgery Partners in a report on Thursday, February 29th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $43.00 target price on shares of Surgery Partners in a research note on Wednesday, April 10th. Citigroup reduced their target price on Surgery Partners from $43.00 to $42.00 and set a “buy” rating for the company in a research note on Tuesday, February 27th. Finally, StockNews.com upgraded Surgery Partners from a “sell” rating to a “hold” rating in a report on Thursday, March 21st. Two equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, Surgery Partners has a consensus rating of “Moderate Buy” and a consensus price target of $43.63.

Surgery Partners Stock Up 0.8 %

Shares of SGRY stock traded up $0.19 on Tuesday, hitting $24.95. The stock had a trading volume of 807,942 shares, compared to its average volume of 891,796. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.71 and a quick ratio of 1.57. The business has a 50 day moving average of $28.30 and a 200 day moving average of $29.78. Surgery Partners, Inc. has a 12-month low of $22.05 and a 12-month high of $45.79. The stock has a market cap of $3.17 billion, a price-to-earnings ratio of -249.50, a price-to-earnings-growth ratio of 2.24 and a beta of 2.71.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings data on Monday, February 26th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.37 by $0.07. Surgery Partners had a negative net margin of 0.43% and a positive return on equity of 3.65%. The firm had revenue of $735.40 million during the quarter, compared to analyst estimates of $741.93 million. During the same quarter last year, the business posted $0.22 EPS. The company’s revenue for the quarter was up 4.0% on a year-over-year basis. As a group, analysts expect that Surgery Partners, Inc. will post 0.78 EPS for the current year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.